
Standard Glass Lining Technology Limited - IPO
MAINBOARDStandard Glass Lining Technology Stock Price


Standard Glass Lining Technology IPO Details
Standard Glass Lining Technology IPO Subscription
Standard Glass Lining Technology IPO Application Wise Breakup (Approx)
Standard Glass Lining Technology IPO Dates
- 06 Jan 2025Opening dateOPD
- 08 Jan 2025Closing dateCOD
- 09 Jan 2025Basis of AllotmentBOA
- 10 Jan 2025Initiation of RefundsIOR
- 10 Jan 2025Credit of SharesCOS
- 13 Jan 2025Listing dateLID
Standard Glass Lining Technology IPO Lot Size
Application | Lots | Shares | Amount |
---|---|---|---|
Retain Minimum | 1 | 107 | ₹14,980 |
Retain Maximum | 13 | 1391 | ₹194,740 |
SHNI Minimum | 14 | 1498 | ₹209,720 |
SHNI Maximum | 66 | 7062 | ₹988,680 |
BHNI Minimum | 67 | 7169 | ₹1,003,660 |
Standard Glass Lining Technology IPO Reservation
Promoter Holding
Standard Glass Lining Technology IPO Valuations
Standard Glass Lining Technology Limited Financial Information
Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | ||||||||||||||||||||||||||||||||||||
Assets | 756.52 | 665.38 | 347.79 | 298.11 | ||||||||||||||||||||||||||||||||||||
Revenue | 312.1 | 549.68 | 500.08 | 241.5 | ||||||||||||||||||||||||||||||||||||
Profit After Tax | 36.27 | 60.01 | 53.42 | 25.15 | ||||||||||||||||||||||||||||||||||||
Net Worth | 447.8 | 409.92 | 156.67 | 69.91 | ||||||||||||||||||||||||||||||||||||
Reserves and Surplus | 261.58 | 389.18 | 139.94 | 53.66 | ||||||||||||||||||||||||||||||||||||
Total Borrowing | 173.8 | 129.32 | 81.96 | 69.81 | ||||||||||||||||||||||||||||||||||||
Amount in ₹ Crore |
About Standard Glass Lining Technology IPO
Incorporated in September 2012, Standard Glass Lining Technology Limited is a manufacturer of engineering equipment for the pharmaceutical and chemical sectors in India. The company has the capability to manage the entire production process in-house.
The company provides turnkey solutions, including design, engineering, manufacturing, assembly, installation, and standard operating procedures for pharmaceutical and chemical manufacturers.
The company's product product portfolio includes
- Reaction Systems;
- Storage, Separation and Drying Systems; and
- Plant, Engineering and Services
The company manufactures specialized engineering equipment using glass-lined materials, stainless steel, and nickel alloy.
The company's customer includes Apitoria Pharma Private Limited, Aurobindo Pharma Limited, CCL Food and Beverages Private Limited, Cohance Lifesciences Limited, Cadila Pharmaceutical Limited, Deccan Fine Chemicals (India) Private Limited, Dasami Lab Private Limited, Laurus Labs Limited, Granules India Limited, Macleods Pharmaceuticals Limited, MSN Laboratories Private Limited, Natco Pharma Limited, Honour Lab Limited, Hetero Drugs Limited, Hetero Labs Limited, Hazelo Lab Private Limited, Piramal Pharma Limited, Sanvira Biosciences Private Limited, Suven Pharmaceuticals Limited, Tagros Chemicals India Private Limited, Vamsi Labs Limited and Viyash Life Sciences Private Limited.
The company has eight manufacturing units situated in Hyderabad, Telangana.
The company's sales offices are situated in Vadodara, Gujarat, Ankleshwar, Gujarat, Mumbai, Maharashtra and Vishakhapatnam, Andhra Pradesh and sales team members are in Jhagadia, Gujarat, Chennai, Tamil Nadu, New Delhi, Bengaluru, Karnataka and Vijayawada, Andhra Pradesh with pan-India reach.
As of September 30, 2024, the company had 460 full-time employees and 731 contract labourers.
Competitive Strength
- Specialised engineering equipment manufacturers for the pharmaceutical and chemical sectors.
- Customized and innovative range of products throughout the entire pharmaceutical and chemical manufacturing value chain.
- Strategically located manufacturing facilities with advanced technological capabilities.
- Long term relationships with marquee clientele across sectors.
- Consistent track record of profitable growth.
Strength Of Standard Glass Lining Technology IPO
1. One of the top five specialised engineering equipment manufacturers for pharmaceutical and chemical sectors in India with products across entire value chain.
2. Customized and innovative product offering across the entire pharmaceutical and chemical manufacturing value chain.
3. Strategically located manufacturing facilities with advanced technological capabilities.
4. Long term relationships with marquee clientele across sectors.
5. Consistent track record of profitable growth.
6. Experienced promoters and management team.
Risk Of Standard Glass Lining Technology IPO
1. We are dependent on our manufacturing facilities, all of which are situated in Telangana, India. We are subject to risks in relation to our manufacturing process including accidents and natural disasters and also risks arising from changes in the economic or political conditions of Telangana, India which in turn will interfere with our operations and could have an adverse effect on our business, results of operations and financial condition.
2. Our business is dependent on the availability and retainment of skilled labour and workforce, and if we are unable to hire and engage the appropriate personnel, our business, results of operations and financial condition shall be adversely affected.
3. Our Manufacturing Facilities are dependent on adequate and uninterrupted supply of electricity and water. Any shortage or disruption of electricity and/or water, may lead to disruption in operations, higher operating cost and consequent decline in our operating margins.
4. Our revenue from operations is dependent upon a limited number of customers and the loss of any of these customers or loss of revenue from any of these customers could have a material adverse effect on our business, financial condition, results of operations and cash flows.
5. We are dependent on a limited number of suppliers for our key raw materials such as stainless steel, carbon/ mild steel, nickel alloy, forgings, castings, chemicals and polytetrafluoroethylene powder. The loss of one or more of these suppliers could adversely impact our manufacturing processes and supply timelines, in turn adversely impacting our ability to comply with delivery schedules agreed with clients resulting in impact on our financial condition and results of operations.
6. Majority of our customers operate in the pharmaceuticals and chemical sectors. In each of the last three Fiscals, more than 94.33% of our revenue from operations were derived from the pharmaceutical and chemical sectors, combined. Factors that adversely affect these sectors or capital expenditure by companies within these sectors may adversely affect our business, results of operations and financial condition.
7. Our Company had in the past failed to comply with certain provisions of Companies Act.
8. Under-utilization of our currently operational production lines at our Manufacturing Facilities and an inability to effectively utilize our expanded manufacturing capacities could have an adverse effect on our business, future prospects, and future financial performance.
9. Our business has grown rapidly in recent periods, and we may not be able to sustain our rate of growth in the future.
10. Nearly all of our revenues for Fiscal 2024, Fiscal 2023 and Fiscal 2022 were derived from sales of products and services within India, which in turn exposes us to risks specific to the Indian geography and market. There can be no assurance that we will be able to diversify the geographic sources of our revenues, which may adversely impact our future results of operations and profitability.
Objectives Standard Glass Lining Technology IPO
- Funding of capital expenditure requirements of the Company towards the purchase of machinery and equipment;
- Repayment or prepayment, in full or in part, of all or a portion of certain outstanding borrowings availed by the Company and investment in the wholly owned Material Subsidiary, S2 Engineering Industry Private Limited, for repayment or prepayment, in full or in part, of all or a portion of certain outstanding borrowings availed by S2 Engineering Industry Private Limited, from banks and financial institutions;
- Investment in the wholly owned Material Subsidiary, S2 Engineering Industry Private Limited, for funding its capital expenditure requirements towards purchase of machinery and equipment;
- Funding inorganic growth through strategic investments and/or acquisitions and
- General corporate purposes
Company Contact Details
Standard Glass Lining Technology Limited
10th Floor, PNR High Nest,
Hydernagar, KPHB Colony
Hyderabad- 500085
Phone: + 040 3518 2204
Email: corporate@standardglr.com
Website: https://www.standardglr.com/
Registrar Contact Details
Lead Mangers
Iifl Securities Ltd
Motilal Oswal Investment Advisors Limited